Te
Norway Commercial Quality (CQ) Head - 1 year contract
Teva Pharmaceuticals
Full-time
Asker, Norway
other-general
Posted:
March 02, 2026
Location:
Asker, Norway, Norway
Job Description
Norway Commercial Quality (CQ) Head - 1 year contract
Date: Feb 10, 2026
Location:
Asker, Norway, 0
Company: Teva Pharmaceuticals
Job Id: 66332
**We Are Teva **
We’re Teva, a leading innovative biopharmaceutical company, enabled by a world-class generics business. Whether it’s innovating in the fields of neuroscience and immunology or delivering high-quality medicine worldwide, we’re dedicated to addressing patients’ needs now and in the future. Here, you will be part of a high-performing, inclusive culture that values fresh thinking and collaboration. You'll have the room to grow, the flexibility to balance life with work, and the opportunity to better health worldwide, together.
**The opportunity**
Responsible as Commercial Quality Head of the country, in alignment with business unit, in
order to ensure products are ...
Date: Feb 10, 2026
Location:
Asker, Norway, 0
Company: Teva Pharmaceuticals
Job Id: 66332
**We Are Teva **
We’re Teva, a leading innovative biopharmaceutical company, enabled by a world-class generics business. Whether it’s innovating in the fields of neuroscience and immunology or delivering high-quality medicine worldwide, we’re dedicated to addressing patients’ needs now and in the future. Here, you will be part of a high-performing, inclusive culture that values fresh thinking and collaboration. You'll have the room to grow, the flexibility to balance life with work, and the opportunity to better health worldwide, together.
**The opportunity**
Responsible as Commercial Quality Head of the country, in alignment with business unit, in
order to ensure products are ...
Apply for this Job
Submit your application for the Norway Commercial Quality (CQ) Head - 1 year contract position at Teva Pharmaceuticals.
Apply Now Save for LaterJob Overview
Job Type:
Full-time
Location:
Asker, Norway
Posted:
March 02, 2026
Deadline:
April 04, 2026